In contrast to the DNA mismatch repair genes PMS2, MLH1, MSH2, and MSH6, germline variants in MSH3 have not been identified in patients with Lynch syndrome, even though they were reported to increase cancer risk37. This evidence concerns the gene MSH3 and cancer.